Literature DB >> 15136169

An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction.

Carl A Gregory1, W Grady Gunn, Alexandra Peister, Darwin J Prockop.   

Abstract

Alizarin red S (ARS) staining has been used for decades to evaluate calcium-rich deposits by cells in culture. It is particularly versatile in that the dye can be extracted from the stained monolayer and assayed. This study describes a sensitive method for the recovery and semiquantification of ARS in a stained monolayer by acetic acid extraction and neutralization with ammonium hydroxide followed by colorimetric detection at 405 nm. This method was three times more sensitive than an older method involving cetylpyridinium chloride (CPC) extraction and resulted in a better signal to noise ratio, especially for weakly stained monolayers. The assay facilitates detailed inspection of mineralization by phase microscopy and semiquantification of the entire monolayer by extraction and quantification. The sensitivity of the assay is improved by the extraction of the calcified mineral at low pH and, since the mineral is already stained in a quantitative manner, there is no requirement for an additional colorimetric quantification step. Furthermore, the linear range is much wider than those of conventional assays for calcium, making dilutions of mineral extracts prior to measurement unnecessary. It has a wide range of potential uses including tumor characterization, mesenchymal stem cell evaluation, and osteogenic compound screening. Although more labor intensive than CPC extraction, the protocol is more sensitive and yields more reliable results for weakly mineralizing samples.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15136169     DOI: 10.1016/j.ab.2004.02.002

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  419 in total

1.  Direct scaffolding of biomimetic hydroxyapatite-gelatin nanocomposites using aminosilane cross-linker for bone regeneration.

Authors:  Chi-Kai Chiu; Joao Ferreira; Tzy-Jiun M Luo; Haixia Geng; Feng-Chang Lin; Ching-Chang Ko
Journal:  J Mater Sci Mater Med       Date:  2012-06-05       Impact factor: 3.896

2.  Effects of age on parathyroid hormone signaling in human marrow stromal cells.

Authors:  Shuanhu Zhou; Ericka M Bueno; Sung Won Kim; Ilaria Amato; Longxiang Shen; Jochen Hahne; Ilan Bleiberg; Paul Morley; Julie Glowacki
Journal:  Aging Cell       Date:  2011-05-25       Impact factor: 9.304

3.  Characterization and in vitro evaluation of bacterial cellulose membranes functionalized with osteogenic growth peptide for bone tissue engineering.

Authors:  Sybele Saska; Raquel Mantuaneli Scarel-Caminaga; Lucas Novaes Teixeira; Leonardo Pereira Franchi; Raquel Alves Dos Santos; Ana Maria Minarelli Gaspar; Paulo Tambasco de Oliveira; Adalberto Luiz Rosa; Catarina Satie Takahashi; Younès Messaddeq; Sidney José Lima Ribeiro; Reinaldo Marchetto
Journal:  J Mater Sci Mater Med       Date:  2012-05-24       Impact factor: 3.896

4.  Scaffold-free culture of mesenchymal stem cell spheroids in suspension preserves multilineage potential.

Authors:  Priya R Baraniak; Todd C McDevitt
Journal:  Cell Tissue Res       Date:  2011-08-11       Impact factor: 5.249

5.  Stromal cell-derived factor-1β potentiates bone morphogenetic protein-2-stimulated osteoinduction of genetically engineered bone marrow-derived mesenchymal stem cells in vitro.

Authors:  Samuel Herberg; Sadanand Fulzele; Nianlan Yang; Xingming Shi; Matthew Hess; Sudharsan Periyasamy-Thandavan; Mark W Hamrick; Carlos M Isales; William D Hill
Journal:  Tissue Eng Part A       Date:  2012-08-21       Impact factor: 3.845

6.  Preadministration of yerba mate (Ilex paraguariensis) helps functional activity and morphology maintenance of MC3T3-E1 osteoblastic cells after in vitro exposition to hydrogen peroxide.

Authors:  Gabrielli Collasanto Ceverino; Paula Katherine Vargas Sanchez; Roger Rodrigo Fernandes; Guilherme Alvarenga Alves; José Bernardo de Santis; Milla Sprone Tavares; Selma Siéssere; Karina Fittipaldi Bombonato-Prado
Journal:  Mol Biol Rep       Date:  2021-01-17       Impact factor: 2.316

7.  Gene Therapy for Bone Repair Using Human Cells: Superior Osteogenic Potential of Bone Morphogenetic Protein 2-Transduced Mesenchymal Stem Cells Derived from Adipose Tissue Compared to Bone Marrow.

Authors:  Sofia Bougioukli; Osamu Sugiyama; William Pannell; Brandon Ortega; Matthew H Tan; Amy H Tang; Robert Yoho; Daniel A Oakes; Jay R Lieberman
Journal:  Hum Gene Ther       Date:  2018-03-14       Impact factor: 5.695

8.  Patient-derived skeletal dysplasia induced pluripotent stem cells display abnormal chondrogenic marker expression and regulation by BMP2 and TGFβ1.

Authors:  Biagio Saitta; Jenna Passarini; Dhruv Sareen; Loren Ornelas; Anais Sahabian; Shilpa Argade; Deborah Krakow; Daniel H Cohn; Clive N Svendsen; David L Rimoin
Journal:  Stem Cells Dev       Date:  2014-04-01       Impact factor: 3.272

9.  Proposing the use of dental pulp stem cells as a suitable biological model of neurofibromatosis type 1.

Authors:  Paula Nascimento Almeida; Gustavo Torres Souza; Camila Maurmann de Souza; Rafaella Souza Salomão de Zanette; Claudinéia Pereira Maranduba; João Vitor Paes Rettore; Marcelo Oliveira de Santos; Antônio Márcio Resende do Carmo; Carlos Magno Costa da Maranduba; Fernando Sá de Silva
Journal:  Childs Nerv Syst       Date:  2014-12-06       Impact factor: 1.475

10.  Controlled release of simvastatin from in situ forming hydrogel triggers bone formation in MC3T3-E1 cells.

Authors:  Yoon Shin Park; Allan E David; Kyung Min Park; Chia-Ying Lin; Khoi D Than; Kyuri Lee; Jun Beom Park; Inho Jo; Ki Dong Park; Victor C Yang
Journal:  AAPS J       Date:  2012-12-19       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.